For instance, by using single-cell gene expression Caruso et al. found TLR2 to be exclusively upregulated in glioma-associated microglia and CRTAM receptor in CD8+ T cells, confirming previous studies (56, 57) that have proposed these molecules as targets for adjuvant immunotherapies in glioma. The gene discussed is TLR2; the disease is central nervous system cancer.